Universal Health Services Inc. - 10-Q Summary (Period Ended June 30, 2001)
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the three and six-month periods ended June 30, 2001, for Universal Health Services Inc. (UHS), a provider of acute care and behavioral health services. The company operates a diverse portfolio of hospitals and facilities in the United States and France. Notably, the company executed a two-for-one stock split effective June 1, 2001, and all share data presented has been adjusted to reflect this split.
Key Financial Metrics
| Metric | Three Months Ended 6/30/01 | Six Months Ended 6/30/01 | Six Months Ended 6/30/00 |
|---|---|---|---|
| Net Revenues | $718.6 million | $1,395.5 million | $1,065.8 million |
| Net Income | $32.4 million | $68.6 million | $51.9 million |
| Diluted EPS | $0.51 | $1.08 | $0.84 |
| EBITDAR | $110.8 million | $224.0 million | $181.4 million |
| Operating Margin | 15.4% | 16.0% | 17.0% |
| Cash from Operations | N/A | $160.1 million | $97.2 million |
| Total Debt (Long-term + Current) | N/A | $664.6 million | $548.8 million (Dec 31, 2000) |
| Cash & Equivalents | $24.5 million | $24.5 million | $10.5 million (Dec 31, 2000) |
Note: EBITDAR is defined as Earnings before interest, income taxes, depreciation, amortization, lease & rental, minority interest expense, and gains/losses on foreign exchange.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 37% ($194 million) for the quarter and 31% ($330 million) for the six-month period compared to 2000. This growth was driven by $110 million (quarter) and $195 million (six-month) in revenue from 27 facilities acquired since Q3 2000, including eight hospitals in France.
- Same-Facility Performance: Revenues at facilities owned in both periods increased 17% for the quarter and 13% for the six-month period, attributed to higher prices from private payors, increased Medicare reimbursements (effective April 1, 2001), and higher patient volumes.
- Margin Compression: Overall operating margins declined from 16.6% to 15.4% (quarter) and 17.0% to 16.0% (six-month). This was primarily due to increased labor costs, pharmaceutical expenses, bad debt provisions (specifically regarding insolvent HMOs in Louisiana and Puerto Rico), and rising insurance premiums.
- Acquisition Activity: The company invested approximately $192 million in acquisitions during the first half of 2001, significantly impacting cash flows from investing activities ($248.6 million used).
Outlook, Risks, and Management Commentary
- Regulatory Impact: The implementation of the Medicare, Medicaid and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA) is expected to increase net revenues and pre-tax income by $5 million to $10 million in 2001. However, the company faces ongoing pressure from the Balanced Budget Act of 1997 (BBA-97) regarding reimbursement rates.
- Cost Pressures: Management anticipates continued pressure on operating margins due to rising labor rates, high-cost drug utilization, and unfavorable trends in commercial liability insurance pricing. The company may need to assume greater self-insurance risk if commercial premiums become prohibitive.
- Liquidity: The company maintains strong liquidity with $225 million of unused capacity under its $400 million revolving credit facility and $25 million under its commercial paper program. Total debt as a percentage of total capitalization rose to 46% from 43%.
- Accounting Changes: The company adopted SFAS No. 133 regarding derivative instruments, resulting in a pre-tax cumulative effect of $7.6 million recorded in other comprehensive income. Future adoption of SFAS 141 and 142 (Goodwill) is expected to impact financial statements starting in 2002.
- Foreign Exchange: The company recorded a $1.3 million pre-tax loss in the first quarter due to foreign exchange fluctuations on an intercompany loan related to its French acquisition, partially offset by hedging gains in the second quarter.
Investor Verification Checklist
- Acquisition Integration: Verify the operational performance and integration status of the 27 facilities acquired since late 2000, particularly the eight hospitals in France.
- Bad Debt Exposure: Assess the specific impact of the two insolvent HMOs in Louisiana and Puerto Rico on future receivables and the adequacy of current reserves.
- Insurance Costs: Monitor the renewal of commercial professional and general liability policies expiring December 31, 2001, and the potential cost impact of increased self-insurance.
- Reimbursement Rates: Track the actual realization of BIPA-related Medicare/Medicaid reimbursement increases versus the estimated $5-$10 million benefit.
- Debt Covenants: Review the terms of the $400 million revolving credit facility and the impact of the increased debt-to-capitalization ratio on borrowing costs and covenants.